These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 8207976)
1. Analysis of mutations and expression of GAP-related domain of the neurofibromatosis type 1 (NF1) gene in the progression of chronic myelogenous leukemia. Nakai H; Misawa S; Horiike S; Taniwaki M; Seriu T; Shimazaki C; Fujii H; Maekawa T; Furukawa T; Abe T Leukemia; 1994 Jun; 8(6):1027-33. PubMed ID: 8207976 [TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of N-RAS and GAP-related domain of the neurofibromatosis type 1 gene in chronic myelogenous leukemia. Garicochea B; Giorgi R; Odone VF; Dorlhiac-Llacer PE; Bendit I Leuk Res; 1998 Nov; 22(11):1003-7. PubMed ID: 9783802 [TBL] [Abstract][Full Text] [Related]
3. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia. Lee YY; Kim WS; Bang YJ; Jung CW; Park S; Yoon WJ; Cho KS; Kim IS; Jung TJ; Choi IY Stem Cells; 1995 Sep; 13(5):556-63. PubMed ID: 8528106 [TBL] [Abstract][Full Text] [Related]
4. Differential expression of two types of the neurofibromatosis type 1 (NF1) gene transcripts related to neuronal differentiation. Nishi T; Lee PS; Oka K; Levin VA; Tanase S; Morino Y; Saya H Oncogene; 1991 Sep; 6(9):1555-9. PubMed ID: 1923522 [TBL] [Abstract][Full Text] [Related]
5. Mutations within the FLR exon of NF1 are rare in myelodysplastic syndromes and acute myelocytic leukemias. Ludwig L; Janssen JW; Schulz AS; Bartram CR Leukemia; 1993 Jul; 7(7):1058-60. PubMed ID: 8321021 [TBL] [Abstract][Full Text] [Related]
6. Genetic alterations in the p53 gene in the blast crisis of chronic myelogenous leukemia: analysis by polymerase chain reaction based techniques. Neubauer A; He M; Schmidt CA; Huhn D; Liu ET Leukemia; 1993 Apr; 7(4):593-600. PubMed ID: 8464238 [TBL] [Abstract][Full Text] [Related]
7. Absence of N-ras mutations in myeloid and lymphoid blast crisis of chronic myeloid leukemia. Watzinger F; Gaiger A; Karlic H; Becher R; Pillwein K; Lion T Cancer Res; 1994 Jul; 54(14):3934-8. PubMed ID: 8033117 [TBL] [Abstract][Full Text] [Related]
8. Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing. Knowles MA; Williamson M Cancer Res; 1993 Jan; 53(1):133-9. PubMed ID: 8093230 [TBL] [Abstract][Full Text] [Related]
9. Infrequent ras activation in chronic myelogenous leukemia (CML): activating 61st codon mutation in the CML-derived cell line, IM-9. Needleman SW; Gutheil JC; Kapil V; Mane SM Leukemia; 1989 Nov; 3(11):827-9. PubMed ID: 2682048 [TBL] [Abstract][Full Text] [Related]
10. Neurofibromatosis 1 gene (NF1) mutation is a rare genetic event in myelodysplastic syndrome regardless of the disease progression. Kaneko H; Horiike S; Nakai H; Ueda Y; Nakao M; Hirakawa K; Yokota S; Taniwaki M; Misawa S; Kashima K Int J Hematol; 1995 Apr; 61(3):113-6. PubMed ID: 7599322 [TBL] [Abstract][Full Text] [Related]
11. Analysis of neurofibromatosis type 1 gene mutation in juvenile chronic myelogenous leukemia. Watanabe I; Horiuchi T; Hatta N; Matsumoto M; Koike K; Kojima S; Ohga S; Fujita S Acta Haematol; 1998; 100(1):22-5. PubMed ID: 9691142 [TBL] [Abstract][Full Text] [Related]
12. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance. Inokuchi K; Yamaguchi H; Tarusawa M; Futaki M; Hanawa H; Tanosaki S; Dan K Leukemia; 2002 Feb; 16(2):170-7. PubMed ID: 11840282 [TBL] [Abstract][Full Text] [Related]
13. Assessment of the potential pathogenicity of missense mutations identified in the GTPase-activating protein (GAP)-related domain of the neurofibromatosis type-1 (NF1) gene. Thomas L; Richards M; Mort M; Dunlop E; Cooper DN; Upadhyaya M Hum Mutat; 2012 Dec; 33(12):1687-96. PubMed ID: 22807134 [TBL] [Abstract][Full Text] [Related]
14. [Molecular study on minute alterations of the p53 and the N-ras genes in hematologic malignancies]. Kurosawa M Hokkaido Igaku Zasshi; 1994 May; 69(3):543-54. PubMed ID: 7927179 [TBL] [Abstract][Full Text] [Related]
15. Characterization of Ras effector mutant interactions with the NF1-GAP related domain. Marshall MS; Hettich LA Oncogene; 1993 Feb; 8(2):425-31. PubMed ID: 8426748 [TBL] [Abstract][Full Text] [Related]
16. Analysis of the GAP-related domain of the neurofibromatosis type 1 (NF1) gene in childhood brain tumors. Scheurlen WG; Senf L Int J Cancer; 1995 Aug; 64(4):234-8. PubMed ID: 7657385 [TBL] [Abstract][Full Text] [Related]
17. Two NF1 mutations: frameshift in the GAP-related domain, and loss of two codons toward the 3' end of the gene. Abernathy CR; Colman SD; Kousseff BG; Wallace MR Hum Mutat; 1994; 3(4):347-52. PubMed ID: 8081387 [TBL] [Abstract][Full Text] [Related]
18. Point mutations in both transforming and non-transforming codons of the N-ras proto-oncogene of Ph+ leukemias. Rovera G; Reichard BA; Hudson S; Bittenbender S; Yamada M; Tournay O; Preisler HD Oncogene; 1989 Jul; 4(7):867-72. PubMed ID: 2666907 [TBL] [Abstract][Full Text] [Related]